ArticleEuropean radiology2026

Deep learning-based radiomics does not improve residual cancer burden prediction post-chemotherapy in LIMA breast MRI trial.

Markus H A Janse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.